The role of human telomerase reverse transcriptase (hTERT) expression in cancer progression and as a diagnostic biomarker in oral squamous cell carcinoma - 03/07/25
, Kavitha Sanjeev b, Rajkumar Krishnan aCet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
Abstract |
Background |
Telomerase is composed of a rate-limiting telomerase reverse transcriptase catalytic subunit and an RNA template component. Telomerase reverse transcriptase (hTERT) is an essential unit of telomerase. The study aimed to immunohistochemically analyze the expression of hTERT in different grades of oral squamous cell carcinoma in relation to the clinicopathological findings.
Methodology |
Tissues procured from 60 histopathologically confirmed cases of oral squamous cell carcinoma were subjected to immunohistochemistry to determine the expression of hTERT. Statistical significance was set at p < 0.05. Chi-square test was employed to compare the staining intensity between the groups. Kappa analysis was done to measure the interobserver agreement (κ = 0.84).
Results |
The size of the tumor ranged from 1.5 cm to 5.5 cm approximately. Regional lymph node metastasis was noted in 2 patients with poorly differentiated OSCC. Distant metastasis was not identified in any of the enrolled patients. 54/60 OSCC patients showed hTERT expression.
Conclusion |
Though we did not find a significant difference in hTERT expression in our study, the role of hTERT in cancer progression and the increase in expression from well-differentiated OSCC to poorly differentiated OSCC suggests that hTERT can serve as a diagnostic biomarker in early stages of OSCC.
Le texte complet de cet article est disponible en PDF.Keywords : Telomeres, Telomerase reverse transcriptase, Oral squamous cell carcinoma, Immunohistochemistry
Plan
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?